Date posted: June 9, 2020, 6:00 am
In this episode, we discuss important nutritional deficiencies as well as pharmacologic changes that occur in post-bariatric surgery patients.
Date posted: May 19, 2020, 6:00 am
In this episode, we review ten clinical pearls about total parenteral nutrition (TPN) that all pharmacists should know.
Date posted: April 28, 2020, 6:00 am
In this episode, we will discuss the most recent evidence for the use of omega-3 fatty acids (fish oil) for ASCVD risk reduction.
Date posted: April 7, 2020, 6:00 am
In this episode, we chat with Eris Tollkuci, PharmD, BCOP regarding what every non-onc healthcare provider should know about immune checkpoint inhibitors (specifically PD-1/PD-L1 inhibitors) in patients with cancer.
Date posted: March 17, 2020, 6:00 am
In this episode, we summarize some of the most significant changes in the newest version of American Diabetes Association - 2020 Standards of Medical Care in Diabetes guidelines.
Date posted: February 25, 2020, 6:00 am
In this episode, we review the pros, cons, and literature regarding the use of DOACs versus warfarin in obese patients with venous thromboembolism.
Date posted: February 4, 2020, 6:00 am
In this episode, we provide an overview of lifestyle medicine, its six pillars, and how it plays a role in improving health outcomes.
Date posted: January 14, 2020, 6:00 am
In this episode, we discuss clinical pearls and management related to chronic and acute hyperkalemia.
Date posted: December 24, 2019, 6:00 am
In this episode, we discuss the important updates in the 2019 IDSA Community Acquired Pneumonia (CAP) guidelines with Dr. Christie Bertram, PharmD, an Infectious Diseases Clinical Pharmacist and Assistant Professor at Ë®ÃÛÌÒÊÓƵ Franklin University’s College of Pharmacy.
Date posted: December 3, 2019, 6:00 am
In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel, ticagrelor) and discuss each agent’s clinical pearls, comparative effectiveness, and unique precautions.